{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:34:23Z","timestamp":1790634863153,"version":"4.1.0"},"reference-count":192,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The loss of cone photoreceptor function in retinitis pigmentosa (RP) severely impacts the central and daily vision and quality of life of patients affected by this disease. The loss of cones follows the degeneration of rods, in a manner independent of the causing mutations in numerous genes associated with RP. We have explored this phenomenon and proposed that the loss of rods triggers a reduction in the expression of rod-derived cone viability factor (RdCVF) encoded by the nucleoredoxin-like 1 (NXNL1) gene which interrupts the metabolic and redox signaling between rods and cones. After providing scientific evidence supporting this mechanism, we propose a way to restore this lost signaling and prevent the cone vision loss in animal models of RP. We also explain how we could restore this signaling to prevent cone vision loss in animal models of the disease and how we plan to apply this therapeutic strategy by the administration of both products of NXNL1 encoding the trophic factor RdCVF and the thioredoxin enzyme RdCVFL using an adeno-associated viral vector. We describe in detail all the steps of this translational program, from the design of the drug, its production, biological validation, and analytical and preclinical qualification required for a future clinical trial that would, if successful, provide a treatment for this incurable disease.<\/jats:p>","DOI":"10.3390\/ijms21051625","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T09:30:36Z","timestamp":1582882236000},"page":"1625","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Metabolic and Redox Signaling of the Nucleoredoxin-Like-1 Gene for the Treatment of Genetic Retinal Diseases"],"prefix":"10.3390","volume":"21","author":[{"given":"Emmanuelle","family":"Cl\u00e9rin","sequence":"first","affiliation":[{"name":"Department of Genetics, Sorbonne Universit\u00e9, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Marussig","sequence":"additional","affiliation":[{"name":"SparingVision, 55 rue de Lyon, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Alain","family":"Sahel","sequence":"additional","affiliation":[{"name":"Department of Genetics, Sorbonne Universit\u00e9, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France"},{"name":"CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DGOS CIC 1423, 28 rue de Charenton, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"L\u00e9veillard","sequence":"additional","affiliation":[{"name":"Department of Genetics, Sorbonne Universit\u00e9, INSERM, CNRS, Institut de la Vision, 17 rue Moreau, F-75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/13816810.2018.1495745","article-title":"Gene therapy in inherited retinal degenerative diseases, a review","volume":"39","author":"Takahashi","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bmb\/ldy005","article-title":"Retinal gene therapy","volume":"126","author":"Kumaran","year":"2018","journal-title":"Br. Med. Bull."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1093\/hmg\/ddz130","article-title":"Has retinal gene therapy come of age? From bench to bedside and back to bench","volume":"28","author":"Trapani","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cell.2018.03.021","article-title":"Gene Therapy for Retinal Degeneration","volume":"173","author":"Apte","year":"2018","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1126\/science.334.6052.29","article-title":"Clinical research. Gene therapists celebrate a decade of progress","volume":"334","author":"Kaiser","year":"2011","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1016\/S0021-9258(18)82319-5","article-title":"Molecular cloning and expression of RPE65, a novel retinal pigment epithelium-specific microsomal protein that is post-transcriptionally regulated in vitro","volume":"268","author":"Hamel","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/ng1097-139","article-title":"Mutations in RPE65 cause Leber\u2019s congenital amaurosis","volume":"17","author":"Marlhens","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/3813","article-title":"Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle","volume":"20","author":"Redmond","year":"1998","journal-title":"Nat. Genet."},{"key":"ref_9","first-page":"23","article-title":"Congenital stationary night blindness in the dog: Common mutation in the RPE65 gene indicates founder effect","volume":"4","author":"Aguirre","year":"1998","journal-title":"Mol. Vis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/43977","article-title":"Virus treatment questioned after gene therapy death","volume":"401","author":"Lehrman","year":"1999","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","article-title":"Gene therapy death prompts review of adenovirus vector","volume":"286","author":"Marshall","year":"1999","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0140-6736(05)74011-3","article-title":"The balance of risk and benefit in gene-therapy trials","volume":"355","author":"Barbour","year":"2000","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis","volume":"358","author":"Bainbridge","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"15112","DOI":"10.1073\/pnas.0807027105","article-title":"Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics","volume":"105","author":"Cideciyan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/526487a","article-title":"Success against blindness encourages gene therapy researchers","volume":"526","author":"Ledford","year":"2015","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120ra15","DOI":"10.1126\/scitranslmed.3002865","article-title":"AAV2 gene therapy readministration in three adults with congenital blindness","volume":"4","author":"Bennett","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"E517","DOI":"10.1073\/pnas.1218933110","article-title":"Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement","volume":"110","author":"Cideciyan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1412965","article-title":"Improvement and decline in vision with gene therapy in childhood blindness","volume":"372","author":"Jacobson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber\u2019s congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Boye, S.E., Huang, W.C., Roman, A.J., Sumaroka, A., Boye, S.L., Ryals, R.C., Olivares, M.B., Ruan, Q., Tucker, B.A., and Stone, E.M. (2014). Natural history of cone disease in the murine model of Leber congenital amaurosis due to CEP290 mutation: Determining the timing and expectation of therapy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092928"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E5844","DOI":"10.1073\/pnas.1509914112","article-title":"Successful arrest of photoreceptor and vision loss expands the therapeutic window of retinal gene therapy to later stages of disease","volume":"112","author":"Beltran","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/bs.pmbts.2015.06.009","article-title":"A History of the Classical Visual Cycle","volume":"134","author":"Wright","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1167\/iovs.10-5559","article-title":"Retinal disease in Rpe65-deficient mice: Comparison to human leber congenital amaurosis due to RPE65 mutations","volume":"51","author":"Caruso","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"8879","DOI":"10.1073\/pnas.1017127108","article-title":"Cone opsin determines the time course of cone photoreceptor degeneration in Leber congenital amaurosis","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: A randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"ref_28","unstructured":"Frison-Roche, R. (1941). Premier de Cord\u00e9e: Roman, J\u2019ai Lu."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.drudis.2019.01.019","article-title":"Luxturna: FDA documents reveal the value of a costly gene therapy","volume":"24","author":"Darrow","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Blond, F., and Leveillard, T. (2019). Functional Genomics of the Retina to Elucidate its Construction and Deconstruction. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194922"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1097-2765(01)00305-7","article-title":"A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11)","volume":"8","author":"Vithana","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cge.12758","article-title":"Variant haploinsufficiency and phenotypic non-penetrance in PRPF31-associated retinitis pigmentosa","volume":"90","author":"Rose","year":"2016","journal-title":"Clin. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM199011083231903","article-title":"Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa","volume":"323","author":"Dryja","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: Implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1073\/pnas.0911991107","article-title":"Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP\/Grp78","volume":"107","author":"Gorbatyuk","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nm0898-967","article-title":"Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa","volume":"4","author":"Lewin","year":"1998","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/hmg\/7.10.1649","article-title":"Ribozymes as therapeutic tools for genetic disease","volume":"7","author":"Phylactou","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1350-9462(00)00007-0","article-title":"Ribozyme uses in retinal gene therapy","volume":"19","author":"Hauswirth","year":"2000","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1877-1173(09)88001-0","article-title":"Rhodopsin-mediated retinitis pigmentosa","volume":"88","author":"Malanson","year":"2009","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1167\/iovs.09-4766","article-title":"Spectrum of rhodopsin mutations in French autosomal dominant rod-cone dystrophy patients","volume":"51","author":"Audo","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_41","first-page":"e38","article-title":"Prevalence of Rhodopsin mutations in autosomal dominant Retinitis Pigmentosa in Spain: Clinical and analytical review in 200 families","volume":"93","author":"Corton","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0002-9394(03)00206-X","article-title":"Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23","volume":"136","author":"Oh","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00417-015-3099-7","article-title":"Retinal histopathology in eyes from patients with autosomal dominant retinitis pigmentosa caused by rhodopsin mutations","volume":"253","author":"Bonilha","year":"2015","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/519025","article-title":"RNA interference-mediated suppression and replacement of human rhodopsin in vivo","volume":"81","author":"Palfi","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"E8547","DOI":"10.1073\/pnas.1805055115","article-title":"Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector","volume":"115","author":"Cideciyan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ymthe.2005.03.028","article-title":"Toward a gene therapy for dominant disease: Validation of an RNA interference-based mutation-independent approach","volume":"12","author":"Kiang","year":"2005","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e96560","DOI":"10.1172\/jci.insight.96560","article-title":"Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15","volume":"2","author":"Botta","year":"2017","journal-title":"JCI Insight"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fnins.2019.00945","article-title":"Gene Editing Preserves Visual Functions in a Mouse Model of Retinal Degeneration","volume":"13","author":"Vagni","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.ymthe.2018.04.017","article-title":"In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation","volume":"26","author":"Moreno","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1167\/iovs.06-0556","article-title":"Caspase-1 ablation protects photoreceptors in a model of autosomal dominant retinitis pigmentosa","volume":"47","author":"Samardzija","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4161\/cc.6.6.4029","article-title":"Programmed cell death in retinal degeneration: Targeting apoptosis in photoreceptors as potential therapy for retinal degeneration","volume":"6","author":"Marigo","year":"2007","journal-title":"Cell Cycle"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1038\/ncomms9005","article-title":"A short N-terminal domain of HDAC4 preserves photoreceptors and restores visual function in retinitis pigmentosa","volume":"6","author":"Guo","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2015.68","article-title":"CNTF Gene Therapy Confers Lifelong Neuroprotection in a Mouse Model of Human Retinitis Pigmentosa","volume":"23","author":"Lipinski","year":"2015","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term Follow-up of Patients with Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants","volume":"170","author":"Birch","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtn.2019.11.005","article-title":"AAV-miR-204 Protects from Retinal Degeneration by Attenuation of Microglia Activation and Photoreceptor Cell Death","volume":"19","author":"Karali","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.1901787116","article-title":"Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa","volume":"116","author":"Wang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1172\/JCI79735","article-title":"NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage","volume":"125","author":"Xiong","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_59","first-page":"2612","article-title":"Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice","volume":"16","author":"Picard","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.18632\/oncotarget.4466","article-title":"mTORC1 sustains vision in retinitis pigmentosa","volume":"6","author":"Petit","year":"2015","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1172\/JCI86905","article-title":"Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration","volume":"126","author":"Zhang","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1073\/pnas.91.3.974","article-title":"Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa","volume":"91","author":"Sung","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","article-title":"Retinitis pigmentosa","volume":"368","author":"Hartong","year":"2006","journal-title":"Lancet"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archopht.1963.00960040682020","article-title":"Jean Nougaret, the butcher from Provence, and his family","volume":"69","author":"Snyder","year":"1963","journal-title":"Arch. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ng0796-358","article-title":"Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness","volume":"13","author":"Dryja","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1755-3768.1991.tb02046.x","article-title":"Autosomal Dominant Stationary Night-Blindness\u2014A Large Family Rediscovered","volume":"69","author":"Rosenberg","year":"1991","journal-title":"Acta Ophthalmol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preteyeres.2014.09.001","article-title":"Congenital stationary night blindness: An analysis and update of genotype-phenotype correlations and pathogenic mechanisms","volume":"45","author":"Zeitz","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng1097-132","article-title":"A searchlight through the fog","volume":"17","author":"Wright","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.6.5.5","article-title":"Restoration of Cone Photoreceptor Function in Retinitis Pigmentosa","volume":"6","author":"Kaplan","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0042-6989(93)90144-L","article-title":"Assessment of foveal cone photoreceptors in Stargardt\u2019s macular dystrophy using a small dot detection task","volume":"33","author":"Geller","year":"1993","journal-title":"Vis. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1172\/JCI95161","article-title":"Patients and animal models of CNG\u03b21-deficient retinitis pigmentosa support gene augmentation approach","volume":"128","author":"Occelli","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/156652307780363143","article-title":"Retinal degenerations: From cell signaling to cell therapy; pre-clinical and clinical issues","volume":"7","author":"Cronin","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/343316a0","article-title":"Molecular-Genetics\u2014Insight into Blindness","volume":"343","author":"Applebury","year":"1990","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000132758","article-title":"Linkage analysis of human chromosome 4: Exclusion of autosomal dominant retinitis pigmentosa (ADRP) and detection of new linkage groups","volume":"50","author":"Daiger","year":"1989","journal-title":"Cytogenet. Cell Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/343364a0","article-title":"A point mutation of the rhodopsin gene in one form of retinitis pigmentosa","volume":"343","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"ref_76","first-page":"487","article-title":"Electron microscopic observations of human retinitis pigmentosa, dominantly inherited","volume":"13","author":"Kolb","year":"1974","journal-title":"Investig. Ophthalmol."},{"key":"ref_77","first-page":"355","article-title":"Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect","volume":"88","author":"Berson","year":"1990","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1073\/pnas.95.12.7103","article-title":"Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man","volume":"95","author":"Cideciyan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","first-page":"489","article-title":"Differential effect of the rd mutation on rods and cones in the mouse retina","volume":"17","author":"LaVail","year":"1978","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/347677a0","article-title":"Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase","volume":"347","author":"Bowes","year":"1990","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng0693-130","article-title":"Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa","volume":"4","author":"McLaughlin","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00305377","article-title":"Cone cells fail to develop normally in transgenic mice showing ablation of rod photoreceptor cells","volume":"275","author":"Usukura","year":"1994","journal-title":"Cell Tissue Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/exer.1996.0089","article-title":"Morphological and physiological consequences of the selective elimination of rod photoreceptors in transgenic mice","volume":"63","author":"McCall","year":"1996","journal-title":"Exp. Eye Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.6.2.4","article-title":"Progression of Pro23His Retinopathy in a Miniature Swine Model of Retinitis Pigmentosa","volume":"6","author":"Scott","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/exer.1993.1056","article-title":"Development and fate of interphotoreceptor matrix components during dysplastic photoreceptor differentiation: A lectin cytochemical study of rod-cone dysplasia 1","volume":"56","author":"Mieziewska","year":"1993","journal-title":"Exp. Eye Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1167\/iovs.10-5347","article-title":"Cone degeneration following rod ablation in a reversible model of retinal degeneration","volume":"52","author":"Choi","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nn.2234","article-title":"Stimulation of the insulin\/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa","volume":"12","author":"Punzo","year":"2009","journal-title":"Nat. Neurosci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000268027","article-title":"Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse","volume":"29","author":"Hicks","year":"1997","journal-title":"Ophthalmic Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archopht.118.6.807","article-title":"Selective transplantation of rods delays cone loss in a retinitis pigmentosa model","volume":"118","author":"Hicks","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1073\/pnas.95.14.8357","article-title":"Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse","volume":"95","author":"Hicks","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1167\/iovs.01-1144","article-title":"Partial characterization of retina-derived cone neuroprotection in two culture models of photoreceptor degeneration","volume":"44","author":"Fintz","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1126\/science.2911751","article-title":"Plasticity and differentiation of embryonic retinal cells after terminal mitosis","volume":"243","author":"Adler","year":"1989","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-4835(90)90013-K","article-title":"Photoreceptor survival-promoting activity in interphotoreceptor matrix preparations: Characterization and partial purification","volume":"50","author":"Hewitt","year":"1990","journal-title":"Exp. Eye Res."},{"key":"ref_94","unstructured":"Hinton, D.R., Schachat, A.P., and Wilkinson, C.P. (2006). Retinitis Pigmentosa and Allied Disorders A2\u2014Ryan, Stephen, J. Retina, Mosby. [4th ed.]. Chapter 17."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng1386","article-title":"Identification and characterization of rod-derived cone viability factor","volume":"36","author":"Leveillard","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cell.2015.03.023","article-title":"Rod-derived cone viability factor promotes cone survival by stimulating aerobic glycolysis","volume":"161","author":"Fridlich","year":"2015","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lambard, S., Reichman, S., Berlinicke, C., Niepon, M.L., Goureau, O., Sahel, J.A., Leveillard, T., and Zack, D.J. (2010). Expression of rod-derived cone viability factor: Dual role of CRX in regulating promoter activity and cell-type specificity. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013075"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/hmg\/ddp484","article-title":"The homeobox gene CHX10\/VSX2 regulates RdCVF promoter activity in the inner retina","volume":"19","author":"Reichman","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Delyfer, M.N., Raffelsberger, W., Mercier, D., Korobelnik, J.F., Gaudric, A., Charteris, D.G., Tadayoni, R., Metge, F., Caputo, G., and Barale, P.O. (2011). Transcriptomic analysis of human retinal detachment reveals both inflammatory response and photoreceptor death. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028791"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/mt.2009.28","article-title":"Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa","volume":"17","author":"Yang","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"26ps16","DOI":"10.1126\/scitranslmed.3000866","article-title":"Rod-derived cone viability factor for treating blinding diseases: From clinic to redox signaling","volume":"2","author":"Leveillard","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00417-013-2314-7","article-title":"Functional rescue of cone photoreceptors in retinitis pigmentosa","volume":"251","author":"Sahel","year":"2013","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1172\/JCI65654","article-title":"Viral-mediated RdCVF and RdCVFL expression protects cone and rod photoreceptors in retinal degeneration","volume":"125","author":"Byrne","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1167\/iovs.02-0995","article-title":"Retina-specific expression of 5A11\/Basigin-2, a member of the immunoglobulin gene superfamily","volume":"44","author":"Ochrietor","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"32285","DOI":"10.18632\/oncotarget.5963","article-title":"Cancer metabolism of cone photoreceptors","volume":"6","author":"Leveillard","year":"2015","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e25946","DOI":"10.7554\/eLife.25946","article-title":"Glycolytic reliance promotes anabolism in photoreceptors","volume":"6","author":"Chinchore","year":"2017","journal-title":"eLife"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Chalmel, F., Leveillard, T., Jaillard, C., Lardenois, A., Berdugo, N., Morel, E., Koehl, P., Lambrou, G., Holmgren, A., and Sahel, J.A. (2007). Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potential. BMC Mol. Biol., 8.","DOI":"10.1186\/1471-2199-8-74"},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Brennan, L.A., Lee, W., and Kantorow, M. (2010). TXNL6 is a novel oxidative stress-induced reducing system for methionine sulfoxide reductase a repair of alpha-crystallin and cytochrome C in the eye lens. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015421"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/cdd.2010.2","article-title":"The disruption of the rod-derived cone viability gene leads to photoreceptor dysfunction and susceptibility to oxidative stress","volume":"17","author":"Cronin","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_110","first-page":"3649","article-title":"Metabolic and redox signaling in the retina","volume":"74","author":"Sahel","year":"2016","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/ars.2015.6509","article-title":"The Thioredoxin Encoded by the Rod-Derived Cone Viability Factor Gene Protects Cone Photoreceptors Against Oxidative Stress","volume":"24","author":"Mei","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","article-title":"Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses","volume":"334","author":"Anastasiou","year":"2011","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1515\/hsz-2014-0295","article-title":"Cytosolic thiol switches regulating basic cellular functions: GAPDH as an information hub?","volume":"396","author":"Hildebrandt","year":"2015","journal-title":"Biol. Chem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"101049","DOI":"10.1016\/j.redox.2018.11.007","article-title":"Thioredoxin and glutaredoxin regulate metabolism through different multiplex thiol switches","volume":"21","author":"McDonagh","year":"2019","journal-title":"Redox Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.freeradbiomed.2018.05.081","article-title":"Selenocysteine in mammalian thioredoxin reductase and application of ebselen as a therapeutic","volume":"127","author":"Ren","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1038\/s41598-019-39901-z","article-title":"A Mathematical Analysis of Aerobic Glycolysis Triggered by Glucose Uptake in Cones","volume":"9","author":"Camacho","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s00018-016-2318-7","article-title":"Metabolic and redox signaling in the retina","volume":"74","author":"Leveillard","year":"2017","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"8475125","DOI":"10.1155\/2017\/8475125","article-title":"Cell Signaling with Extracellular Thioredoxin and Thioredoxin-Like Proteins: Insight into Their Mechanisms of Action","volume":"2017","author":"Leveillard","year":"2017","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1093\/hmg\/ddz148","article-title":"Next-generation AAV vectors-do not judge a virus (only) by its cover","volume":"28","author":"Domenger","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_120","first-page":"63","article-title":"RPGR gene therapy presents challenges in cloning the coding sequence","volume":"9","author":"MacLaren","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2016.039","article-title":"Effects of Self-Complementarity, Codon Optimization, Transgene, and Dose on Liver Transduction with AAV8","volume":"27","author":"Bell","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1073\/pnas.89.22.10892","article-title":"Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo","volume":"89","author":"Dai","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0378-1119(89)90209-6","article-title":"Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5","volume":"79","author":"Miyazaki","year":"1989","journal-title":"Gene"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2015.01.003","article-title":"Thioredoxin rod-derived cone viability factor protects against photooxidative retinal damage","volume":"81","author":"Elachouri","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0896-6273(91)90355-4","article-title":"Unusual topography of bovine rhodopsin promoter-lacZ fusion gene expression in transgenic mouse retinas","volume":"6","author":"Zack","year":"1991","journal-title":"Neuron"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nature08401","article-title":"Gene therapy for red-green colour blindness in adult primates","volume":"461","author":"Mancuso","year":"2009","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/gt.2009.46","article-title":"Independent and high-level dual-gene expression in adult stem-progenitor cells from a single lentiviral vector","volume":"16","author":"Tian","year":"2009","journal-title":"Gene Ther."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.celrep.2013.03.012","article-title":"Definition of RNA polymerase II CoTC terminator elements in the human genome","volume":"3","author":"Nojima","year":"2013","journal-title":"Cell Rep."},{"key":"ref_129","unstructured":"Parrish, C., and Berns, K. (2007). Parvoviridae. Fields Virology, Lippincott Williams & Wilkins. [5th ed.]."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1089\/hum.1996.7.17-2101","article-title":"Quantitative analysis of the packaging capacity of recombinant adeno-associated virus","volume":"7","author":"Dong","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"9933","DOI":"10.1128\/JVI.79.15.9933-9944.2005","article-title":"Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps","volume":"79","author":"Grieger","year":"2005","journal-title":"J. Virol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mt.2009.255","article-title":"Effect of genome size on AAV vector packaging","volume":"18","author":"Wu","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.mt.6300389","article-title":"Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer","volume":"16","author":"Bennicelli","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/genetics\/140.3.875","article-title":"Transcription termination signals in the nin region of bacteriophage lambda: Identification of Rho-dependent termination regions","volume":"140","author":"Cheng","year":"1995","journal-title":"Genetics"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ymthe.2005.06.003","article-title":"Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery","volume":"12","author":"Chadeuf","year":"2005","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1128\/jvi.71.4.3077-3082.1997","article-title":"Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats","volume":"71","author":"Wang","year":"1997","journal-title":"J. Virol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymthe.2017.09.007","article-title":"Otx2-Genetically Modified Retinal Pigment Epithelial Cells Rescue Photoreceptors after Transplantation","volume":"26","author":"Kole","year":"2018","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1089\/hum.2017.159","article-title":"Plasmid DNA Manufacturing for Indirect and Direct Clinical Applications","volume":"28","author":"Schmeer","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.omtm.2018.01.002","article-title":"Pharmacology of Recombinant Adeno-associated Virus Production","volume":"8","author":"Francois","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jgm.1126","article-title":"Novel AAV serotypes for improved ocular gene transfer","volume":"10","author":"Lebherz","year":"2008","journal-title":"J. Gene Med."},{"key":"ref_141","first-page":"317","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"Biodrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Vandenberghe, L.H., Bell, P., Maguire, A.M., Xiao, R., Hopkins, T.B., Grant, R., Bennett, J., and Wilson, J.M. (2013). AAV9 targets cone photoreceptors in the nonhuman primate retina. PLoS ONE, 8.","DOI":"10.1371\/annotation\/64b90996-4634-4c63-b737-634397b0b445"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/hum.2012.125","article-title":"The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina","volume":"23","author":"Boye","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/hum.2009.092","article-title":"Producing recombinant adeno-associated virus in foster cells: Overcoming production limitations using a baculovirus-insect cell expression strategy","volume":"20","author":"Virag","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1089\/hum.2017.042","article-title":"Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines","volume":"28","author":"Kotin","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.ymthe.2017.08.003","article-title":"Direct Head-to-Head Evaluation of Recombinant Adeno-associated Viral Vectors Manufactured in Human versus Insect Cells","volume":"25","author":"Kondratov","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1600193","DOI":"10.1002\/biot.201600193","article-title":"Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms","volume":"12","author":"Robert","year":"2017","journal-title":"Biotechnol. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J. Gen. Virol."},{"key":"ref_149","first-page":"383","article-title":"Binding of the Rb1 protein to E1A products is required for adenovirus transformation","volume":"4","author":"Egan","year":"1989","journal-title":"Oncogene"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.gene.2004.06.054","article-title":"Reduction of adenovirus E1A mRNA by RNAi results in enhanced recombinant protein expression in transiently transfected HEK293 cells","volume":"341","author":"Hacker","year":"2004","journal-title":"Gene"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1128\/jvi.65.12.6447-6453.1991","article-title":"The ability of large T antigen to complex with p53 is necessary for the increased life span and partial transformation of human cells by simian virus 40","volume":"65","author":"Lin","year":"1991","journal-title":"J. Virol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/biot.201500176","article-title":"Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (AAV) productivity in mammalian cells","volume":"11","author":"Emmerling","year":"2016","journal-title":"Biotechnol. J."},{"key":"ref_154","unstructured":"World Health Organization (2006). WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies, World Health Organization."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/hgtb.2015.051","article-title":"Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications","volume":"26","author":"Strobel","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.omtm.2017.12.004","article-title":"Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes","volume":"9","author":"Nass","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtm.2019.09.006","article-title":"Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2","volume":"15","author":"Wang","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_159","first-page":"16019","article-title":"Practical utilization of recombinant AAV vector reference standards: Focus on vector genomes titration by free ITR qPCR","volume":"5","author":"Blouin","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/hgtb.2013.131","article-title":"Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR","volume":"25","author":"Lock","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Strain, M.C., Lada, S.M., Luong, T., Rought, S.E., Gianella, S., Terry, V.H., Spina, C.A., Woelk, C.H., and Richman, D.D. (2013). Highly precise measurement of HIV DNA by droplet digital PCR. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055943"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Clement","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/mt.2009.256","article-title":"Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb","volume":"18","author":"Lai","year":"2010","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1167\/iovs.04-0541","article-title":"Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system","volume":"45","author":"Prusky","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Clerin, E., Wicker, N., Mohand-Said, S., Poch, O., Sahel, J.A., and Leveillard, T. (2011). e-conome: An automated tissue counting platform of cone photoreceptors for rodent models of retinitis pigmentosa. BMC Ophthalmol., 11.","DOI":"10.1186\/1471-2415-11-38"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4614-0631-0_18","article-title":"Dark-rearing the rd10 mouse: Implications for therapy","volume":"723","author":"Cronin","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Barone, I., Novelli, E., Piano, I., Gargini, C., and Strettoi, E. (2012). Environmental enrichment extends photoreceptor survival and visual function in a mouse model of retinitis pigmentosa. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050726"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"107773","DOI":"10.1016\/j.exer.2019.107773","article-title":"Sex-related differences in the progressive retinal degeneration of the rd10 mouse","volume":"187","author":"Li","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3389\/fnins.2019.01234","article-title":"Investigations into Bioenergetic Neuroprotection of Cone Photoreceptors: Relevance to Retinitis Pigmentosa","volume":"13","author":"Narayan","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_170","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2009). Guideline ICH. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3 (R2). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH."},{"key":"ref_171","unstructured":"European Medicines Agency (2008). Guideline on the Non-Clinical Studies Required Before First Clinical Use of Gene Therapy Medicinal Products, EMA."},{"key":"ref_172","unstructured":"The Food and Drug Administration (2018). Gene Therapy Guidance Document: Guidance for Industry: Preclinical Assessment of Investigational Cellular and Gene Therapy Products (2013), The Food and Drug Administration."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.omtm.2019.08.011","article-title":"Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates","volume":"15","author":"Weed","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1172\/JCI129085","article-title":"AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression","volume":"130","author":"Ding","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Bruewer, A.R., Mowat, F.M., Bartoe, J.T., Boye, S.L., Hauswirth, W.W., and Petersen-Jones, S.M. (2013). Evaluation of lateral spread of transgene expression following subretinal AAV-mediated gene delivery in dogs. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060218"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"E9391","DOI":"10.1073\/pnas.1808903115","article-title":"Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors","volume":"115","author":"Singh","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1038\/s41598-018-31488-1","article-title":"Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography","volume":"8","author":"Jauregui","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1038\/s41598-017-10473-0","article-title":"Retrospective Analysis of Structural Disease Progression in Retinitis Pigmentosa Utilizing Multimodal Imaging","volume":"7","author":"Cabral","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2019.3298","article-title":"Clinical Characterization of Retinitis Pigmentosa Associated With Variants in SNRNP200","volume":"137","author":"Yusuf","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1038\/s41598-018-26231-9","article-title":"Assessment of Central Visual Function in Patients with Retinitis Pigmentosa","volume":"8","author":"Fujiwara","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.ophtha.2015.05.039","article-title":"Visual Function in Carriers of X-Linked Retinitis Pigmentosa","volume":"122","author":"Comander","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2018.10.003","article-title":"Natural History Study of Retinal Structure, Progression, and Symmetry Using Ellipzoid Zone Metrics in RPGR-Associated Retinopathy","volume":"198","author":"Tee","year":"2019","journal-title":"Am. J. Ophthalmol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1167\/iovs.18-24931","article-title":"Progression in X-linked Retinitis Pigmentosa Due to ORF15-RPGR Mutations: Assessment of Localized Vision Changes Over 2 Years","volume":"59","author":"Cideciyan","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2017.02.016","article-title":"Impact of Retinitis Pigmentosa on Quality of Life, Mental Health, and Employment Among Young Adults","volume":"177","author":"Cariou","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_185","unstructured":"Osterberg, G. (1935). Topography of the Layer of Rods and Cones in the Human Retina, Levin & Munksgaard."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ophtha.2014.02.023","article-title":"International Nomenclature for Optical Coherence Tomography. Proposed lexicon for anatomic landmarks in normal posterior segment spectral-domain optical coherence tomography: The IN*OCT consensus","volume":"121","author":"Staurenghi","year":"2014","journal-title":"Ophthalmology"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.8.3.37","article-title":"Reliability of Spectral-Domain OCT Ellipsoid Zone Area and Shape Measurements in Retinitis Pigmentosa","volume":"8","author":"Smith","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/02713683.2015.1079328","article-title":"Quantification of the Visual Field Loss in Retinitis Pigmentosa Using Semi-Automated Kinetic Perimetry","volume":"41","author":"Nowomiejska","year":"2016","journal-title":"Curr. Eye Res."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1167\/iovs.16-21302","article-title":"Quantifying Fundus Autofluorescence in Patients with Retinitis Pigmentosa","volume":"58","author":"Schuerch","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_190","first-page":"1934","article-title":"Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa","volume":"36","author":"Sandberg","year":"1995","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"20130508","DOI":"10.1098\/rspb.2013.0508","article-title":"The nocturnal bottleneck and the evolution of activity patterns in mammals","volume":"280","author":"Gerkema","year":"2013","journal-title":"Proc. Biol. Sci. R. Soc."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1093\/hmg\/dds050","article-title":"Nxnl2 splicing results in dual functions in neuronal cell survival and maintenance of cell integrity","volume":"21","author":"Jaillard","year":"2012","journal-title":"Hum. Mol. Genet."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1625\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:02:10Z","timestamp":1760173330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/5\/1625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":192,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["ijms21051625"],"URL":"https:\/\/doi.org\/10.3390\/ijms21051625","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]}}}